# A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds

> **NCT07467239** · NA · RECRUITING · sponsor: **Samyang Biopharmaceuticals Corporation** · enrollment: 30 (estimated)

## Conditions studied

- Nasolabial Folds, Wrinkles

## Interventions

- **DEVICE:** DMFI300
- **DEVICE:** Ellansé-M

## Key facts

- **NCT ID:** NCT07467239
- **Lead sponsor:** Samyang Biopharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07467239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07467239, "A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07467239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*